Coronary Artery Bypass Graft Devices Market Report

Coronary Artery Bypass Graft Devices Market Analysis, Market Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2014 To 2020

Format: PDF  |  Report ID: GVR1236

Rising prevalence of cardiovascular disorders, increasing geriatric population base coupled and growing need for repeat revascularization procedure are the major growth propellers of coronary artery bypass graft devices (CABG) market. Increasing incidences of coronary heart diseases resulting due to unhealthy lifestyle is another high impact rendering driver for this market. The introduction of minimally invasive devices (minimally invasive direct coronary artery bypass, MIDCAB), anastomosis assist devices (AAD) and endoscopic vessel harvesting (EVH) devices are also impacting the market growth positively. MIDCABs are being very popular recently due to the benefits of reduced risk of infection, less recovery time, less bleeding and smaller incision. 

Based on the number of coronary arteries used in the bypass surgery, the market is segmented into single, double, triple and quadruple CABG surgery. This depends on the number of stenosis the patient is suffering from. On the basis of the techniques used, this market is segmented into on-pump CABG (ONCAB) and off-pump CABG (OPCAB). An ONCAB procedure needs cardiopulmonary bypass or heart-lung machine, whereas OPCAB procedures are held in the absence of heart-lung machines. OPCAB is relatively newer technology and is expected to be the fastest growing segment in the next six years. 

Coronary artery bypass graft devices market is globally divided into North America, Europe, and Asia Pacific and RoW. North America and Europe market for CABG is matured one with all the versions of minimally invasive CABG surgeries available and is expected to have the largest share during the forecast period. In Europe, this market is expected to gain volumes due to rising numbers of coronary diseases. Due to the increase in medical tourism industry and growth in per capita income in Asian countries, the Asia-Pacific market is expected to flourish in the forecast period. China is expected to be the fastest growing market for these devices attributed to the growing access of public with healthcare professional and expanding economy. 

The major players in this market are Heratport, Medtronic, Guidant, Terumo, Maquet, Sorin Group, St. Jude Medicals, Edward Life sciences, Heartwave, Boston Scientific, Thoratec, Articure, Teleflex Medicals and Biosense Webster. ONCAB, OPCAB, AAD, and EVH are majorly marketed by Maquet.

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,950
Multi User - $5,950
Library Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA